MEDIMMUNE, WYETH TO LAUNCH RESPIGAM FOR RSV PROPHYLAXIS IN SEPTEMBER WITH PARENT EDUCATION; PHARMACOECONOMIC STUDIES WILL BE PROMOTED TO MCOs